Key Developments: Centene Corp (CNC.N)

CNC.N on New York Stock Exchange

55.66USD
17 Apr 2014
Price Change (% chg)

$-1.29 (-2.27%)
Prev Close
$56.95
Open
$55.96
Day's High
$56.84
Day's Low
$55.16
Volume
226,200
Avg. Vol
122,693
52-wk High
$67.84
52-wk Low
$43.51

Search Stocks

Latest Key Developments (Source: Significant Developments)

Centene Corporation purchases noncontrolling interest in Spanish Health Management Group
Monday, 7 Apr 2014 04:51pm EDT 

Centene Corp:Signs definitive agreement to purchase noncontrolling interest in Ribera Salud S.A., a Spanish health management group.Centene will be joint shareholder with Ribera Salud S.A.'s remaining investor, Banco Sabadell, the fourth largest private bank in Spain.Transaction is expected to close in 2014.  Full Article

Centene Corp raises FY 2014 revenue guidance; reaffirms FY 2014 EPS guidance
Tuesday, 4 Feb 2014 06:00am EST 

Centene Corp:Now expects premium and service revenues for FY 2014 to be between $13.8-$14.3 billion.EPS to be between $3.50-$3.80.FY 2014 revenue of $13.93 billion, EPS of $3.64- Thomson Reuters I/B/E/S Estimates.  Full Article

Centene Corp's Mississippi subsidiary awarded statewide medicaid contract
Monday, 3 Feb 2014 06:00am EST 

Centene Corp:Says the state of Mississippi has awarded its subsidiary, Magnolia Health Plan, a statewide managed care contract to continue serving members enrolled in the Mississippi Coordinated Access Network (MississippiCAN) program, as one of two contractors.Says under the new contract, Magnolia will continue providing outpatient, behavioral health, pharmacy, vision and dental services, and will also begin providing non-emergency transportation as of July 01.  Full Article

Centene Corp announces public offering by selling stockholder
Monday, 27 Jan 2014 04:23pm EST 

Centene Corp:Says it has announced an underwritten public offering of 800,000 shares of its common stock by one of its existing stockholders.Says it will not receive any proceeds from the sale of shares by the selling stockholder in the offering, and its total number of shares outstanding will not change as a result of the offering.Says Barclays Capital Inc. is acting as sole underwriter in this offering.  Full Article

Centene Corp reaffirms FY 2013 revenue guidance, raises low end of prior FY 2013 EPS guidance - Conference Call
Monday, 13 Jan 2014 12:30pm EST 

Centene Corp:Says for FY 2013 its revenue guidance is unchanged and expects at $10.6 bln to $10.8 bln range.Says FY 2013 EPS of $2.81 to $2.87, which we had tightened up on its last earnings call.FY 2013 EPS of $2.83 per share - Thomson Reuters I/B/E/S.  Full Article

Centene Corp completes acquisition of U.S. Medical Management
Tuesday, 7 Jan 2014 09:12am EST 

Centene Corp:Completes the purchase of a majority interest in U.S. Medical Management, LLC.Says as previously announced, the purchase price for Centene's majority interest is about $200 mln and was funded with a combination of about one-third cash and two-thirds Centene stock.  Full Article

Centene Corp to acquire majority stake in Fidelis SecureCare of Michigan
Wednesday, 18 Dec 2013 08:00am EST 

Centene Corp:Says it has signed a definitive agreement to purchase a majority stake in Fidelis SecureCare of Michigan, Inc a subsidiary of Fidelis SeniorCare, Inc.Says fidelis SecureCare was recently selected by the Michigan Department of Community Health as one of six health plans to provide integrated healthcare services to members who are dually eligible for Medicare and Medicaid in Macomb and Wayne counties.Says the program is expected to serve approximately 90,000 of the dual-eligible beneficiaries in the state, with enrollment expected to commence in the fourth quarter of 2014.Says transaction is expected to close in the fourth quarter of 2014.  Full Article

Centene Corp gives FY 2014 guidance
Friday, 13 Dec 2013 06:30am EST 

Centene Corp:Expects premium and service revenues for FY 2014 to be between $13.5-$14.0 billion representing growth of 29 pct.For FY 2014 earnings per diluted share (EPS) are expected to be $3.50 to $3.80, representing an increase of 29 pct compared to the FY 2013 guidance range of $2.81 to $2.87.FY 2014 revenue of $13.8 billion, EPS of $3.63- Thomson Reuters I/B/E/S Estimates.  Full Article

Centene Corp acquires majority interest in U.S. medical management
Thursday, 12 Dec 2013 07:00am EST 

Centene Corp:Says it has signed a definitive agreement to purchase a majority interest in U.S. Medical Management, LLC.Says transaction is expected to close in the first quarter of 2014.Says purchase price for Centene's majority interest is approximately $200 million and is anticipated to be funded with a combination of approximately one-third cash and two-thirds Centene stock.  Full Article

Centene Corp Raises FY 2013 Revenue Guidance; Narrows FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates
Tuesday, 22 Oct 2013 06:01am EDT 

Centene Corp announced that for fiscal 2013, it expects premium and service revenues of $10.6 billion to $10.8 billion and diluted earnings per share (EPS) of $2.77 to $2.87. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $10.8 billion and EPS of $2.79 for fiscal 2013.  Full Article

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, Apr 17,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

Search Stocks